Responses
Clinical and epidemiological research
Concise report
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
Compose a Response to This Article
Other responses
No responses have been published for this article.